Intended for healthcare professionals


Trial will make HIV prevention drugs available on NHS from September

BMJ 2017; 358 doi: (Published 03 August 2017) Cite this as: BMJ 2017;358:j3758
  1. Gareth Iacobucci
  1. The BMJ

Pre-exposure prophylaxis (PrEP) to prevent HIV infection will be available on the NHS when a landmark clinical trial starts in September 2017, NHS England has announced.

The three year trial will provide HIV prevention drugs to an estimated 10 000 people through sexual health clinics, which will identify eligible participants at risk of infection, including men, women, transgender people, and participants whose partner’s HIV is not known to be controlled by antiretroviral treatment.

The announcement comes after NHS England lost an appeal in 2016 against a High Court ruling that the NHS was responsible for commissioning PrEP for HIV prevention.1 NHS England had previously …

View Full Text

Log in

Log in through your institution


* For online subscription